These studies have shown that nearly 20% of NB patients show amplification of MYCN oncogene while non-MYCN amplified NB cases display other chromosomal rearrangements such as 3p, 4p, 11q loss or 1q, 2p, and 17q gains. The gene discussed is MYCN; the disease is neuroblastoma.